When measuring the fields that were still occupied with HUVECs, we found that stimulation with soluble CXCL9 increased the disruption of the monolayer after melanoma treatment, whereas CXCL9 treatment by itself had no effect (Figure 6B). This evidence concerns the gene CXCL9 and melanoma.